# The Safety and Immunogenicity of Acellular Pertussis Vaccine in Bone Marrow Transplant Recipients

> **NCT00336115** · PHASE4 · UNKNOWN · sponsor: **Queen Elizabeth II Health Sciences Centre** · enrollment: 10 (estimated)

## Conditions studied

- Pertussis

## Interventions

- **BIOLOGICAL:** Tetanus and Diphtheria Toxoids Adsorbed Combined with Acellular Pertussis (Adacel)

## Key facts

- **NCT ID:** NCT00336115
- **Lead sponsor:** Queen Elizabeth II Health Sciences Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-07
- **Primary completion:** —
- **Final completion:** 2008-05
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2007-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00336115

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00336115, "The Safety and Immunogenicity of Acellular Pertussis Vaccine in Bone Marrow Transplant Recipients". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00336115. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*